HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guy Cavet Selected Research

Melanoma (Melanoma, Malignant)

9/2007Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guy Cavet Research Topics

Disease

8Rheumatoid Arthritis
01/2021 - 10/2012
7Neoplasms (Cancer)
01/2018 - 12/2005
3Breast Neoplasms (Breast Cancer)
08/2009 - 07/2008
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2007 - 12/2005
1Malaria
01/2024
1Typhoid Fever (Typhoid)
10/2021
1Infections
01/2019
1Ebola Hemorrhagic Fever
11/2018
1Rheumatic Diseases (Rheumatism)
07/2013
1Colorectal Neoplasms (Colorectal Cancer)
08/2009
1Genomic Instability
04/2009
1Hyperlipidemias (Hyperlipidemia)
10/2007
1Melanoma (Melanoma, Malignant)
09/2007
1Pancreatic Neoplasms (Pancreatic Cancer)
09/2007
1Alzheimer Disease (Alzheimer's Disease)
11/2006
1Lung Neoplasms (Lung Cancer)
12/2005

Drug/Important Bio-Agent (IBA)

9Biomarkers (Surrogate Marker)IBA
05/2015 - 12/2005
53-benzoyl dopamine (MBDA)IBA
05/2015 - 10/2012
3Monoclonal AntibodiesIBA
01/2024 - 08/2009
3AntibodiesIBA
10/2021 - 01/2018
1Carrier Proteins (Binding Protein)IBA
10/2021
1Polysaccharides (Glycans)IBA
10/2021
1VaccinesIBA
10/2021
1CytokinesIBA
01/2021
1Immunoglobulin G (IgG)IBA
01/2019
1Neutralizing AntibodiesIBA
11/2018
1Neoplasm Antigens (Tumor Antigens)IBA
01/2018
1Immunoglobulins (Immunoglobulin)IBA
01/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2015
1Tumor Necrosis Factor InhibitorsIBA
05/2015
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2013
1mavrilimumabIBA
09/2013
1pyridinolineIBA
08/2013
1CollagenIBA
08/2013
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
08/2009
1Estrogen ReceptorsIBA
08/2009
1Estrogen Receptor Modulators (Antiestrogen)IBA
08/2009
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2009
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
07/2009
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
07/2009
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
04/2009
1TensinsIBA
04/2009
1taxaneIBA
07/2008
1monomethyl auristatin EIBA
07/2008
1Antimitotic AgentsIBA
07/2008
1Paclitaxel (Taxol)FDA LinkGeneric
07/2008
1Phenobarbital (Luminal)FDA Link
07/2008
1DNA (Deoxyribonucleic Acid)IBA
06/2008
1Ritonavir (Norvir)FDA Link
10/2007
1GlycosyltransferasesIBA
09/2007
1Death Domain ReceptorsIBA
09/2007
1LigandsIBA
09/2007
1Messenger RNA (mRNA)IBA
09/2007
1Proteins (Proteins, Gene)FDA Link
11/2006
1Amyloid beta-PeptidesIBA
11/2006
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
11/2006
1ErbB Receptors (EGF Receptor)IBA
12/2005
1Cadherins (E-Cadherin)IBA
12/2005
1Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2005

Therapy/Procedure

5Therapeutics
05/2015 - 09/2007
1Drug Therapy (Chemotherapy)
12/2005